Medifirst Solutions Quick Ratio (MFST) starting from the third quarter 2019 to third quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Medifirst Solutions, Inc.  (MFST)

Medifirst Solutions's Quick Ratio

MFST's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2019, Quick Ratio deteriorated to 0.15 below Medifirst Solutions's average Quick Ratio.

Within Medical Equipment & Supplies industry 167 other companies have achieved higher Quick Ratio than Medifirst Solutions in third quarter 2019. While Quick Ratio total ranking has improved so far during the Q3 2019 to 3890, from total ranking in the second quarter 2019 at 3891.

Explain Quick Ratio?
How much Cash & cash equivalents MFST´s has?
What are MFST´s Current Liabilities?




MFST Quick Ratio (Sep 30 2019)
Q3
(Jun 30 2019)
Q2
(Mar 31 2019)
Q1
(Dec 31 2018)
Q4
(Sep 30 2018)
Q3
Y / Y Current Liabilities Change 36.35 % 29.73 % 74.6 % 23.31 % -20.12 %
Y / Y Cash & cash equivalent Change 267.43 % 80.95 % 17.46 % -70.84 % -81.24 %
Quick Ratio MRQ 0.15 0.16 0.12 0.06 0.06
MFST's Total Ranking # 3890 # 3891 # 3893 # 4246 # 4557
Seq. Current Liabilities Change -3.62 % -9 % 50.91 % 3.01 % -8.3 %
Seq. Cash & cash equivalent Change -8.28 % 13.6 % 228.85 % 7.24 % -54.83 %



Quick Ratio third quarter 2019 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 168
Healthcare Sector # 859
Overall Market # 3890


Quick Ratio Statistics
High Average Low
47.28 2.18 0
(Jun 30 2014)   (Dec 31 2014)




Financial Statements
Medifirst Solutions's Current Liabilities $ 2 Millions Visit MFST's Balance sheet
Medifirst Solutions's Cash & cash equivalent $ 0 Millions Visit MFST's Balance sheet
Source of MFST's Sales Visit MFST's Sales by Geography


Cumulative Medifirst Solutions's Quick Ratio

MFST's Quick Ratio for the trailling 12 Months

MFST Quick Ratio

(Sep 30 2019)
12 Months
(Jun 30 2019)
12 Months
(Mar 31 2019)
12 Months
(Dec 31 2018)
12 Months
(Sep 30 2018)
12 Months
Y / Y Current Liabilities TTM Growth 40.53 % 22.89 % 24.07 % 4.65 % -0.4 %
Y / Y Cash & cash equivalent TTM Growth 24.11 % -32.48 % -47.82 % -45.1 % -15.53 %
Quick Ratio TTM 0.13 0.11 0.09 0.1 0.14
Total Ranking TTM # 5265 # 3377 # 4908 # 4890 # 4791
Seq. Current Liabilities TTM Growth 7.27 % 6.93 % 16.56 % 5.1 % -6.19 %
Seq. Cash & cash equivalent TTM Growth 27.84 % 22.94 % 7.19 % -26.33 % -30.45 %


On the trailing twelve months basis MFST Cash & cash equivalent more than doubled by 267.43 % in Q3 2019 year on year, faster than Current Liabilities, this led to increase in in Medifirst Solutions's Quick Ratio to 0.13, Quick Ratio remained below MFST average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 213 other companies have achieved higher Quick Ratio than Medifirst Solutions. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2019 from 3377 to 5265.

Explain Quick Ratio?
How much Cash & cash equivalents MFST´s has?
What are MFST´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 214
Healthcare Sector # 971
Within the Market # 5265


trailing twelve months Quick Ratio Statistics
High Average Low
12 1.5 0.07
(Dec 31 2014)  




Companies with similar Quick Ratio in the quarter ending Sep 30 2019, within Medical Equipment & Supplies Industry Quick RatioSep 30 2019 MRQ Cash & cash equivalentSep 30 2019 MRQ Current Liabilities
Neovasc Inc   0.36 $ 5.293  Millions$ 14.722  Millions
Invo Fertility Inc   0.34 $ 2.010  Millions$ 5.914  Millions
Venus Concept Inc   0.32 $ 8.915  Millions$ 27.894  Millions
Tearlab Corp  0.32 $ 9.354  Millions$ 29.312  Millions
National Vision Holdings Inc   0.31 $ 94.086  Millions$ 303.898  Millions
Omnova Solutions Inc  0.31 $ 36.800  Millions$ 119.700  Millions
Stimcell Energetics Inc   0.29 $ 0.353  Millions$ 1.217  Millions
T2 Biosystems Inc   0.28 $ 16.213  Millions$ 57.088  Millions
United Health Products Inc   0.27 $ 0.088  Millions$ 0.324  Millions
Cantel Medical Corp   0.27 $ 49.285  Millions$ 183.397  Millions
Merit Medical Systems Inc  0.26 $ 37.315  Millions$ 141.561  Millions
Alcon inc   0.26 $ 839.000  Millions$ 3,218.000  Millions
Dentsply Sirona Inc   0.26 $ 226.100  Millions$ 868.900  Millions
Envista Holdings Corporation  0.25 $ 193.200  Millions$ 760.700  Millions
Conmed Corporation  0.24 $ 30.068  Millions$ 123.474  Millions
Biolase Inc   0.24 $ 2.403  Millions$ 10.070  Millions
Logicmark Inc  0.23 $ 1.351  Millions$ 5.790  Millions
Milestone Scientific Inc   0.22 $ 1.711  Millions$ 7.647  Millions
Livanova Plc  0.22 $ 75.313  Millions$ 347.723  Millions
Gi Dynamics Inc   0.21 $ 1.403  Millions$ 6.732  Millions
Wright Medical Group N v   0.20 $ 147.263  Millions$ 743.654  Millions
Nexgel Inc   0.18 $ 0.088  Millions$ 0.498  Millions
Escalon Medical Corp   0.17 $ 0.416  Millions$ 2.432  Millions
Encision Inc   0.15 $ 0.142  Millions$ 0.916  Millions
Medifirst Solutions, Inc.  0.15 $ 0.288  Millions$ 1.939  Millions
Infusystem Holdings Inc  0.14 $ 3.157  Millions$ 21.814  Millions
Fuse Medical Inc   0.14 $ 1.031  Millions$ 7.338  Millions
Interpace Biosciences Inc   0.14 $ 2.358  Millions$ 17.296  Millions
Zimmer Biomet Holdings Inc   0.14 $ 512.500  Millions$ 3,773.900  Millions
Qhslab Inc   0.13 $ 0.001  Millions$ 0.009  Millions

Date modified: 2026-09-08T15:09:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.